Trinity Biotech Plc (TRIB)

Trinity Biotech (TRIB) Income Statement


Trinity Biotech Income Statement

Last quarter (Q4 2022), Trinity Biotech's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Trinity Biotech's net income was $―. See Trinity Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 56.74M$ 74.78M$ 92.97M$ 101.98M$ 90.44M$ 97.03M
Cost of Revenue
$ 40.93M$ 52.73M$ 54.89M$ 53.40M$ 52.31M$ 55.59M
Gross Profit
$ 15.81M$ 22.05M$ 38.08M$ 48.58M$ 38.12M$ 41.45M
Operating Expense
$ 21.35M$ 33.30M$ 24.51M$ 28.30M$ 37.94M$ 34.74M
Operating Income
$ -5.54M$ -11.26M$ 13.56M$ 20.28M$ 183.00K$ 6.71M
Net Non Operating Interest Income Expense
$ -12.40M$ 303.00K$ -5.87M$ -6.71M$ -5.88M$ -2.96M
Other Income Expense
$ -2.81M$ -91.36M$ -6.94M$ -20.20M$ -24.30M$ -26.93M
Pretax Income
$ -20.75M$ -41.19M$ 751.00K$ -6.63M$ -30.00M$ -23.18M
Tax Provision
$ -176.00K$ -192.00K$ -178.00K$ -620.00K$ -1.01M$ -525.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -30.93M$ -41.01M$ 875.00K$ -6.39M$ -28.91M$ -22.09M
Basic EPS
$ -1.02$ -1.52$ 0.04$ -0.32$ -1.40$ -1.04
Diluted EPS
$ -1.02$ -1.52$ 0.04$ -0.32$ -1.40$ -1.04
Basic Average Shares
$ 96.63M$ 134.94M$ 20.90M$ 20.90M$ 20.90M$ 20.90M
Diluted Average Shares
$ 96.63M-$ 26.63M$ 26.26M$ 25.47M$ 25.88M
Dividend Per Share
--$ 0.00$ 0.00$ 0.00$ 0.00
Total Operating Income As Reported
Reported Normalized Basic E P S
---$ 3.00$ -0.78-
Reported Normalized Diluted E P S
---$ 3.00--
Rent Expense Supplemental
Total Expenses
$ 62.28M$ 86.03M$ 79.40M$ 81.70M$ 90.25M$ 90.33M
Net Income From Continuing And Discontinued Operation
$ -20.57M$ -41.01M$ 875.00K$ -6.39M$ -28.91M$ -22.09M
Normalized Income
$ -18.68M-$ 6.00M$ 12.30M$ -5.51M$ 3.67M
Interest Expense
$ 12.73M-$ 5.46M$ 5.54M$ 6.58M$ 5.08M
$ -8.02M$ -41.50M$ 6.21M$ -1.10M$ -23.41M$ -18.10M
$ -7.01M$ -39.16M$ 8.95M$ 1.98M$ -18.52M$ -13.98M
Currency in USD

Trinity Biotech Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis